Pierce Capital Research (Formerly Steve Wagner | Invest)

Pierce Capital Research (Formerly Steve Wagner | Invest)

Share this post

Pierce Capital Research (Formerly Steve Wagner | Invest)
Pierce Capital Research (Formerly Steve Wagner | Invest)
Discounted Assets, Premium Potential: The Case for Coherus Oncology

Discounted Assets, Premium Potential: The…

Steve Wagner
Jun 9
1

Share this post

Pierce Capital Research (Formerly Steve Wagner | Invest)
Pierce Capital Research (Formerly Steve Wagner | Invest)
Discounted Assets, Premium Potential: The Case for Coherus Oncology

Taking a Look at Coherus Oncology (CHRS), Special Situation Arbitrage Idea.

Read →
Comments
User's avatar
© 2025 Pierce Capital Research
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share